Guangdong Biolight Meditech Co., Ltd. (300246.SZ)
CNY 7.6
(-0.78%)
CNY 7.6
(-0.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.19 Billion | 1.18 Billion | 1.09 Billion | 1.39 Billion | 825.96 Million | 813.38 Million |
| Cost of Revenue | 812.49 Million | 826.41 Million | 734.62 Million | 743.76 Million | 497.46 Million | 510.61 Million |
| Gross Profit | 381.5 Million | 357.28 Million | 356.39 Million | 652.24 Million | 328.49 Million | 302.77 Million |
| Operating Expenses | 435.22 Million | 329.02 Million | 257.95 Million | 207.86 Million | 225.87 Million | 205.98 Million |
| Selling, General and Administrative Expenses | 186.85 Million | 195.9 Million | 137.93 Million | 110.83 Million | 142.91 Million | 139.15 Million |
| Research and Development Expenses | 85.84 Million | 87.54 Million | 74.33 Million | 57.16 Million | 45.43 Million | 42.35 Million |
| Other Expenses | 211.82 Million | -3.54 Million | 1.67 Million | 2.77 Million | -281.33 Thousand | -1.54 Million |
| Cost and Expenses | 1.24 Billion | 1.15 Billion | 992.58 Million | 951.63 Million | 723.34 Million | 716.59 Million |
| Operating Income | -26.08 Million | 25.68 Million | 76.19 Million | 414.41 Million | 89.83 Million | 93.02 Million |
| Interest Expense | 14.88 Million | 11.51 Million | 11.97 Million | 12.52 Million | 8.38 Million | 2.04 Million |
| Income Tax Expense | 14.8 Million | -2.36 Million | 10.61 Million | 64.92 Million | 16.5 Million | 13.25 Million |
| Earnings before Tax | -46.15 Million | 22.13 Million | 77.87 Million | 417.18 Million | 89.55 Million | 91.48 Million |
| Net Income | -65.18 Million | 22.13 Million | 63.79 Million | 346.14 Million | 64.71 Million | 64.19 Million |
| Earnings Per Share Basic | -0.25 | 0.08 | 0.29 | 1.58 | 0.30 | 0.29 |
| Earnings Per Share Diluted | -0.25 | 0.08 | 0.29 | 1.58 | 0.30 | 0.29 |
| Weighted Average Shares Outstanding | 263.9 Million | 259.2 Million | 219.13 Million | 219.13 Million | 219.13 Million | 219.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 263.9 Million | 259.2 Million | 219.13 Million | 219.71 Million | 219.13 Million | 219.13 Million |
| Gross Margin | 0.32 | 0.30 | 0.33 | 0.47 | 0.40 | 0.37 |
| EBIT Margin | 0.03 | 0.08 | 0.13 | 0.33 | 0.14 | 0.13 |
| Profit Margin | -0.05 | 0.02 | 0.06 | 0.25 | 0.08 | 0.08 |
| EBITDA | 36.24 Million | 95.08 Million | 135.96 Million | 454.25 Million | 117.87 Million | 107.62 Million |
| Earnings Before Tax Margin | -0.02 | 0.02 | 0.07 | 0.30 | 0.11 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 271.03 Million | 269.6 Million | 264.99 Million | 1.19 Billion | 242.28 Million | 286.49 Million |
| Cost of Revenue | 200 Million | 194.16 Million | 193.83 Million | 805.51 Million | 166.33 Million | 203.58 Million |
| Gross Profit | 71.02 Million | 75.44 Million | 71.15 Million | 388.48 Million | 75.94 Million | 82.9 Million |
| Operating Expenses | 71.25 Million | 75.88 Million | 76.41 Million | 306.5 Million | 77.18 Million | 71.68 Million |
| Selling, General and Administrative Expenses | 126.55 Million | 27.82 Million | 57.99 Million | - | -9.36 Million | 94.03 Million |
| Research and Development Expenses | 18.43 Million | 19.61 Million | 18.43 Million | - | 25.08 Million | 19.98 Million |
| Other Expenses | -73.74 Million | -2.22 Million | 10.09 Thousand | -20.06 Million | -15.14 Million | -732.23 Thousand |
| Cost and Expenses | 271.25 Million | 270.04 Million | 270.25 Million | 1.11 Billion | 243.52 Million | 275.26 Million |
| Operating Income | -5.14 Million | -4.89 Million | -5.26 Million | -26.08 Million | -110.13 Million | 9.54 Million |
| Interest Expense | 7.56 Million | 9.22 Million | 3.94 Million | 14.88 Million | 4.05 Million | 3.82 Million |
| Income Tax Expense | 3.63 Million | -1.75 Million | 669.83 Thousand | 14.8 Million | 4.51 Million | 981.98 Thousand |
| Earnings before Tax | -6.68 Million | -7.11 Million | 5.73 Million | -46.15 Million | -125.27 Million | 8.81 Million |
| Net Income | -11.12 Million | -6.14 Million | 3.62 Million | -65.18 Million | -129.46 Million | 5.42 Million |
| Earnings Per Share Basic | -0.04 | -0.02 | 0.01 | - | -0.49 | 0.02 |
| Earnings Per Share Diluted | -0.04 | -0.02 | 0.01 | - | -0.49 | 0.02 |
| Weighted Average Shares Outstanding | 261.6 Million | 262.72 Million | 263.5 Million | 263.9 Million | 264.57 Million | 264.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 261.6 Million | 262.72 Million | 263.5 Million | 263.9 Million | 264.57 Million | 264.57 Million |
| Gross Margin | 0.26 | 0.28 | 0.27 | 0.33 | 0.31 | 0.29 |
| EBIT Margin | 0.00 | 0.02 | 0.04 | - | -0.05 | 0.05 |
| Profit Margin | -0.04 | -0.02 | 0.01 | -0.05 | -0.53 | 0.02 |
| EBITDA | 885.45 Thousand | 5.32 Million | 10.07 Million | - | -11.54 Million | 14.16 Million |
| Earnings Before Tax Margin | -0.02 | -0.02 | -0.02 | -0.02 | -0.45 | 0.03 |
PSSR
WALMEX
NYAX
2646
2462
5596